ICGEB will provide the technical know-how and pre-clinical expertise and Sun Pharma to develop this drug with appropriate pre-clinical & clinical studies to register it in India and other global markets
The agreement involved transfer of these two marketing divisions, along with employees to Strides, for Rs 165 crore Sun Pharmaceutical Industries has completed the process of selling two divisions of erstwhile Ranbaxy Laborat
The company is trying to control costs that have spiralled since it bought Ranbaxy Laboratories Sun Pharmaceutical Industries is looking to divest a manufacturing plant in Ireland as it tries to control costs that have spiral
Net sales has been registered at Rs 6,522 crores Sun Pharmaceutical Industries has posted its financials for first quarter ending June 30, 2015. The financials for Q1FY16 include several one-time and exceptional charges relat
Those who have been asked to resign are Indrajit Banerjee, President and CFO; Yugal Sikri, country head (India) Ranbaxy; Maninder Singh, V-P marketing; Govind Jaju, global head, sourcing; Ratul Bahaduri, director-finance; amo
Stocks of Sun Pharmaceutical made a comeback at the bourses today, rising nearly 3 per cent, a day after Japanese drugmaker Daiichi Sankyo sold its entire stake of around 9 per cent in the company for Rs 20,025 crore.
Sun Pharmaceutical Industries has received RBI nod for transfer of overseas investments of Ranbaxy to it and issue its shares to the non-resident shareholders of the latter as part of their $4-billion merger deal